summaryrefslogtreecommitdiff
path: root/academic/finchtv/COMPANY
diff options
context:
space:
mode:
authorPetar Petrov <petar.petrov@student.oulu.fi>2015-04-11 22:39:24 +0700
committerWilly Sudiarto Raharjo <willysr@slackbuilds.org>2015-04-11 22:39:24 +0700
commitd700c3eee3311aab6626f03e04e6e41befcd53fd (patch)
tree9c471b75afc09700f5d269a08f2395e733433157 /academic/finchtv/COMPANY
parent2a8cbdbdf9b424b624cc92e9cfde29812e60b427 (diff)
downloadslackbuilds-d700c3eee3311aab6626f03e04e6e41befcd53fd.tar.gz
academic/finchtv: Added (Brilliant Trace Viewer).
Signed-off-by: Willy Sudiarto Raharjo <willysr@slackbuilds.org>
Diffstat (limited to 'academic/finchtv/COMPANY')
-rw-r--r--academic/finchtv/COMPANY51
1 files changed, 51 insertions, 0 deletions
diff --git a/academic/finchtv/COMPANY b/academic/finchtv/COMPANY
new file mode 100644
index 0000000000..702989c3ce
--- /dev/null
+++ b/academic/finchtv/COMPANY
@@ -0,0 +1,51 @@
+About Geospiza (http://www.geospiza.com/Company/default.shtml)
+
+Geospiza is a leading developer of enterprise-class software systems
+for workflow management of genetic analysis.
+
+Geospiza has established itself as the life science industry’s top
+software developer for meeting the combined laboratory, data
+management and analytical needs of biotechnology and pharmaceutical
+companies, universities, researchers, contract core and diagnostic
+laboratories involved in genetic testing and manufacturing bio-
+therapeutics.
+
+The life sciences field is rapidly evolving beyond sequencing genomes
+for pure research to developing clinically relevant initiatives such
+as understanding what genetic information is useful for drug
+development, determining drug efficacy, toxicity screening and
+diagnosing infectious agents.
+
+This expansion of the field is resulting in a dramatic increase in the
+amount of data that must be managed by genetic testing laboratories
+and research institutions. Underscoring this growth is the desire by
+the Food & Drug Administration (FDA) and the broader healthcare
+community to match drugs more specifically to a person's individual
+genetic profile. The FDA is expected to focus on the sensitivity and
+accuracy of these new diagnostics, thereby increasing the need for
+verifiable, repeatable processes for testing.
+
+Today, the amount of manual work required to manage and make sense of
+the vast amounts of genetic information being generated by clinical
+and life science research laboratories worldwide is tremendous. In
+order to be able to scale to meet this increased demand and scrutiny
+in a cost-effective way, automated solutions are required.
+
+Geospiza makes software for crunching the vast amounts of genetic
+data. When a laboratory uses GeneSifter Lab Edition, they are able to
+significantly increase capacity, reduce their backlog, eliminate
+errors due to manual processes, and speed time to discovery. The
+software is being used today worldwide by leading institutions and
+laboratories for everything from clinical DNA testing and bio-
+therapeutic manufacturing to contract core lab services and basic
+research and discovery.
+
+Geospiza's products are designed and built by biologists, enabling
+researchers to focus on the science, not the software.
+
+
+More Information
+info.geospiza@perkinelmer.com
+Call (206) 633-4403.
+
+©Copyright 2013 PerkinElmer, Inc. All rights reserved.